
BRUSSELS – the unprofitable market for ensuring more independence for millions of French people in their autumn years will be turned turned into a growth leg in the future, declares Danish medtech firm Qufora, which is betting heavily on exports to the market to its south.
”France is our most underexploited close market, so if we are to increase our footprint in Europe, that will be an important place to enter,” CEO of Qufora Lena Ehmsen Lachenmeier tells MedWatch.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app